Neogen Corporation (NEOG)
Nasdaq · Healthcare · Medical Devices
$13.01+7.08%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $2.8B
- Forward P/E
- 34.2
- 52-week range
- $5.37 – $14.26
- 52-week change
- +117.35%
- EPS (trailing)
- −$0.04
- Analyst rating
- 2.0 Buy
- Next earnings
- Oct 6, 2026
Fiscal year to May 2026
- Revenue
- $870M (−2.72%)
- Net income
- −$7.9M
- Operating margin
- −2.5%
- Diluted EPS
- −$0.04
- Free cash flow
- $31.9M
From the company’s annual report on SEC EDGAR.
About Neogen Corporation
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns for food producers and processors. It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems used for administering antibiotics and vaccines under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand.
Headquarters: Lansing, United States · 2,636 employees · neogen.com